| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| filingDate |
2004-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34d0bfd0772bc61cd0bfca723e8710c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0bfb8dc1c3c3cab5d602f85fe8234c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b47f1ffb46f60e3390e497eff190362a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8122d29e6bce6248b384528568aec7fa |
| publicationDate |
2007-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007141141-A1 |
| titleOfInvention |
Pharmaceutical composition |
| abstract |
An immediate release pharmaceutical composition comprising 4-(3′-chloro-4′-fluoroanilino)-7-methoxy-6-(3-mor-pholinopropoxy)quinazoline or a pharmaceutically-acceptable salt thereof (the Agent); a water-soluble acid; and a water-soluble cellulose ether or an ester of a water-soluble cellulose ether. The claimed compositions inhibit the rate of precipitation of the Agent from solution and/or provide enhanced solubilisation of the agent at pH levels similar to those of the upper GI tract. The claimed compositions are expected to be useful in reducing inter-patient and/or intra-patient variability in exposure to the Agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471418-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011142770-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113616606-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3302565-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8257482-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017223018-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107666914-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10813937-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010071591-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102068423-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065250-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464779-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180015232-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10894049-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013142849-A1 |
| priorityDate |
2003-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |